BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial

Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...

September 21, 2023 | News

SomaLogic and Korea’s DNA Link Join Forces to Expand SomaScan® Platform in Asia-Pacific Proteomics Market

SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, announced its partnership with DNA Link, an innovator in personalized a...

September 20, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Caliway Completes Recruitment for CBL-514 Cellulite Treatment Phase 2 Study

The CBL-0201EFP Phase 2-stage 2 study is an open-label trial that will evaluate the efficacy, safety, and tolerability of CBL-514 in treating subjects with...

September 20, 2023 | News

Breaking Barriers to Health Equity: Empowering Clinical Trial Access in Asia

Clinical trials play a pivotal role in advancing medical knowledge and improving healthcare outcomes. However, a significant challenge in a...

September 13, 2023 | Analysis

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In additio...

September 13, 2023 | News

Thermo Fisher Speeds Up Cell Therapy Manufacturing with Next-Gen Gibco™ CTS™ Dynabeads™ Platform

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)...

September 07, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"

In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC delve into the recently i...

September 06, 2023 | News

ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001

Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...

September 06, 2023 | News

Genmab and Seagen Report TIVDAK® Success in Cervical Cancer Survival Trial

Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...

September 05, 2023 | News

ABM Therapeutics Initiates Phase I Study of ABM-1310 in BRAF V600 Brain Tumors

ABM-1310, the company's proprietary clinical candidate developed as a next-generation BRAF inhibitor and demonstrated superior properties in pre-clinical a...

September 04, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...

September 04, 2023 | News

Bayer Expands Finerenone Clinical Program for Heart Failure

Recruiting approximately 15,000 patients, MOONRAKER is expected to be one of the largest heart failure (HF) study programs to date1,2,3,4 Bayer continue...

September 01, 2023 | News

Stay Connected